Results for first quarter 2015 for Medistim ASA
Results for first quarter 2015 for Medistim ASA
Sales for the quarter ended at MNOK 57.9 (MNOK
48.9), an increase of 18.5 %. Operating profit
(EBIT) ended at MNOK 9.9 (MNOK 7.2), up 36.7 %.
There was a strong development in sales in the US
with an increase in sales with 50 %. Currency
neutral growth in the US was 19 %. VeriQC was
cleared for sale in China during the quarter.
Medtronic is not renewing the distribution agreement
with Medistim Norge AS.